Morphic Holding, Inc. (MORF) shares ended the last trading session 18.7% higher at $31.84. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
WALTHAM, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...
Investors in Morphic Holding Inc (Symbol: MORF) saw new options become available this week, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and ...
Morf Media Inc. sees 100 customer pilot milestone in queue for Morf Learning cloud platform with adaptive learning technology and gamification for mobiles SAN FRANCISCO–(BUSINESS WIRE)–February 26, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results